Analysis of the same populations in muMt−/− tumor-bearing mice showed a significant increase in the late intermediately mature splenic NK cell population, CD27+CD11b+, between the control wild-type and muMt−/−, and the ranitidine-treated wild-type and muMt−/− mice (Figures 7C,D). This evidence concerns the gene CD27 and neoplasm.